Leading dental products manufacturer stops selling amalgam 

In the clearest sign yet that amalgam is headed to the dustbins of history, Dentsply Sirona – the world’s largest manufacturer of dental products – has exited the amalgam market.  In its annual report to the U.S. Securities and Exchange Commission, this industry behemoth quietly noted: “[W]e have discontinued sales for all amalgam products as of December 2020.”

The coup de grâce for Dentsply appears to have been U.S. Food and Drug Administration’s recommendation against amalgam use in high-risk populations.  As Dentsply explained:

Continue reading

FDA doubles down with new amalgam infographics

Showing its interest in the public learning about its recommendation against amalgam use in children, young women, and people with kidney and neurological disease (plus others), the U.S. Food and Drug Administration (FDA) has released two infographics to reinforce its point.  These infographics are also available in Spanish.

You can help make sure FDA’s infographics get into the hands of every patient, family member, friend, neighbor, and colleague in your network by…

  • Printing and distributing FDA’s infographics. You can post them on community bulletin boards or if you are a health professional you can display them in your office.
  • Sharing FDA’s infographics on FacebookTwitter, and other social media. Try using this hashtag: #mercuryfree
  • Incorporating FDA’s infographics into your website or e-newsletter.

Circulating FDA’s new infographics is an important step toward protecting vulnerable populations from amalgam – and a first step toward ending all amalgam use for everybody!

New FDA safety communication recommends against amalgam use for millions of Americans

The U.S. Food and Drug Administration issued a safety communication recommending against amalgam use in people who are at higher risk from the adverse effects of mercury exposure, including…

  • Pregnant women and their developing babies
  • Women who are planning to become pregnant
  • Nursing women and their newborns and infants
  • Children, especially those younger than six years of age
  • People with pre-existing neurological disease
  • People with impaired kidney function
  • People with known heightened sensitivity (allergy) to mercury or other components of dental amalgam.

Continue reading

FDA advisory committee calls for action on amalgam

After we launched the Chicago Declaration to End Dental Industry Mercury Use at the University of Illinois School of Public Health 18 months ago, some of the signatories obtained meetings with the U.S. Food and Drug Administration (FDA) at high levels, persuading the agency to re-open the amalgam issue.  On November 13-14, an FDA scientific advisory committee met to discuss metal implants and specifically dental amalgam.   Continue reading

48,000+ signatures on petition urging FDA to ban mercury fillings for children

With the European Union banning amalgam for children, pregnant women, and breastfeeding mothers, U.S. World Alliance for Mercury-Free Dentistry affiliate Consumers for Dental Choice now spearheads the campaign to get the U.S. Food and Drug Administration (FDA) bureaucracy to catch up!  They kicked it off with a petition calling for FDA to ban mercury fillings in these vulnerable populations like the European Union did.

To the 48,000+ folks who already signed – thank you! If you haven’t signed yet, please take 30 seconds to sign by clicking hereContinue reading